{"title":"The Efficacy of Azelastine in the Prophylaxis of Acute Upper Respiratory Tract Infections","authors":"M. Simon","doi":"10.1089/088318703322751327","DOIUrl":null,"url":null,"abstract":"Azelastine is a potent and selective second-generation histamine H 1 receptor antagonist. It also effectively down regulates expression of the intracellular adhesion molecule-1 (ICAM1) receptor, which plays an important role in human rhinovirus, Coxsackie type A viruses, adenovirus type 5, human parainfluenza virus type 2 and 3, and respiratory syncytial virus mucosal attachment as well as mobilization of immune effector cells. Therapies aimed at reducing ICAM-1 expression should reduce episodes of viral airway infection. This study shows that azelastine prophylaxis may reduce the occurrence of Upper Respiratory Infections (URIs), otitis media, sinusitis, and pharyngitis in otherwise healthy children. (Pediatr Asthma Allergy Immunol 2003;16[4]:275‐ 282.)","PeriodicalId":88951,"journal":{"name":"Pediatric asthma, allergy & immunology","volume":"16 1","pages":"275-282"},"PeriodicalIF":0.0000,"publicationDate":"2003-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric asthma, allergy & immunology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/088318703322751327","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7
Abstract
Azelastine is a potent and selective second-generation histamine H 1 receptor antagonist. It also effectively down regulates expression of the intracellular adhesion molecule-1 (ICAM1) receptor, which plays an important role in human rhinovirus, Coxsackie type A viruses, adenovirus type 5, human parainfluenza virus type 2 and 3, and respiratory syncytial virus mucosal attachment as well as mobilization of immune effector cells. Therapies aimed at reducing ICAM-1 expression should reduce episodes of viral airway infection. This study shows that azelastine prophylaxis may reduce the occurrence of Upper Respiratory Infections (URIs), otitis media, sinusitis, and pharyngitis in otherwise healthy children. (Pediatr Asthma Allergy Immunol 2003;16[4]:275‐ 282.)